Many patients and doctors refuse to apply the ‘g’ word to highly curable cancers, but some survivors draw hope from the ‘good’
Nov. 10, 2016
| By Bill Briggs / Fred Hutch News Service
Derided by some survivors and embraced by others, the phrase “good cancer” surged in use as cure rates rose for some malignancies, pushing that upbeat description into the fervent world of cancer language.
Men with a certain type of aggressive prostate cancer may benefit from therapy that cycles hormones through high peaks and low valleys, small study finds
Jan. 7, 2015
| By Dr. Rachel Tompa / Fred Hutch News Service
A new study from researchers at Johns Hopkins Hospital and Fred Hutchinson Cancer Research Center shows that a certain type of prostate cancer, after months or years of testosterone deprivation, can develop a lethal sensitivity to testosterone in a new treatment approach – “bipolar androgen therapy” – which combines high-dose testosterone with androgen-blocking therapy.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.